Trichosanatine - CAS 169626-16-8

Trichosanatine and squamosamide, as potential candidates as lead compounds for further study in drug development process with the PP2A- α protein. Trichosanatine can alleviate oxidized low-density lipoprotein induced endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway.

LDL, p38 MAPK, MMP, Lipoxygenase, ROS

Immunology/Inflammation, Metabolism, Proteases/Proteasome, MAPK

169602

C27H28N2O4

444.52

[C@@H](CC1=CC=CC=C1)(NC(=O)C2=CC=CC=C2)C(OCC(CN=C(C)C3=CC=CC=C3)O)=O

-20°C

Ice Packs

Natural Product